Data collection study to establish a predictive model of infection observed during childhood cancer therapy using data captured by wearable technology.
Paediatric, adolescent or young adult diagnosis of cancer AND receiving therapy placing them at risk of infection
Receiving cancer treatment at The Royal Children's Hospital
Patients aged 5-18 years at time of the eligibility screening
If aged < 16 years, parent or guardian able to provide consent
<5 years of age.
<16 years of age without guardian or parent consent.
Aged 16-18 and unable to provide consent.
Participant did not consent to wearing Apple Watch for a period of 4 weeks.